<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01402232</url>
  </required_header>
  <id_info>
    <org_study_id>Y20110721</org_study_id>
    <nct_id>NCT01402232</nct_id>
  </id_info>
  <brief_title>Reduction of Risk for Contrast Nephropathy</brief_title>
  <acronym>REICIN</acronym>
  <official_title>Reduction of Risk for Contrast-Induced Nephropathy: A Multicentre Observational Study of Contrast-Induced Nephropathy Following Coronary Angiography or Percutaneous Coronary Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangdong General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangzhou General Hospital of Guangzhou Military Command</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Southern Medical University, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hainan People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Guangdong General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To raise optimal strategies for reduction of risk of contrast-induced nephropathy according
      to several combinations of different risk factors and clinical practice and determine and
      supply the guidance for clinical practice
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. To identify risk factors of contrast-induced nephropathy on the base of literatures and
           the dates of our previous researches.

        2. To develop a predictive model of contrast-induced nephropathy after coronary or
           percutaneous coronary intervention.

        3. To raise optimal strategies for reduction of risk of contrast-induced nephropathy
           according to several combinations of different risk factors and clinical practice and
           determine and supply the guidance for clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>contrast-induced nephropathy</measure>
    <time_frame>48-72 h</time_frame>
    <description>Contrast-Induced Nephropathy was defined as an increase in serum creatinine of more than 0.5 mg/dl from the baseline within 48-72 h of contrast exposure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>An early abnormal increase in serum creatinine</measure>
    <time_frame>24h</time_frame>
    <description>An early abnormal increase in serum creatinine in serum defined as an increase in serum creatinine of more than 0.5 mg/dl from the baseline within 24h of contrast exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse clinical events</measure>
    <time_frame>1month</time_frame>
    <description>Major adverse clinical events: death, requiring renal replacement therapy, 2nd myocardial infarction,target revascularization,acute heart failure, mechanical ventilation,2nd angina,tachyarrhythmia,hypotension,intra-aortic balloon pump and stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse clinical events</measure>
    <time_frame>1year</time_frame>
    <description>Major adverse clinical events: death, requiring renal replacement therapy, 2nd myocardial infarction,target revascularization,acute heart failure, mechanical ventilation,2nd angina,tachyarrhythmia,hypotension,intra-aortic balloon pump and stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>An early abnormal increase in serum cystatin C</measure>
    <time_frame>24h</time_frame>
    <description>An early abnormal increase in serum cystatin C was defined as an increase more than 10% from the baseline within 24h of contrast exposure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Contrast Induced Nephropathy</condition>
  <arm_group>
    <arm_group_label>coronary angiography</arm_group_label>
    <description>We review all consecutive patients who were undergoing coronary angiography</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        We reviewed all consecutive patients who were undergoing coronary angiography
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who agreed to stay in the hospital for 1-3 days after coronary angiography

          -  provided written informed consent

        Exclusion Criteria:

          -  pregnancy

          -  lactation

          -  intravascular administration of an contrast medium within the previous seven days

          -  treatment with metformin,aminoglycosides,N-acetylcysteine (NAC),nonsteroidal

          -  anti-inflammatory drugs within the previous 48 h

          -  intake of nephrotoxic drugs within the previous seven days

          -  history of serious reactions to contrast mediums

          -  severe concomitant disease - renal transplantation , or end-stage renal disease
             necessitating dialysis

          -  patients who died during coronary angiography
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jiyan Chen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Guangdong Cardiovascular Institute,Guangdong General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yingling Zhou, MD</last_name>
    <role>Study Director</role>
    <affiliation>Guangdong Cardiovascular Institute,Guangdong General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yong Liu, MD</last_name>
    <role>Study Director</role>
    <affiliation>Guangdong Cardiovascular Institute,Guangdong General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ning Tan, MD</last_name>
    <role>Study Director</role>
    <affiliation>Guangdong Cardiovascular Institute,Guangdong General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pingyan Chen, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Southern Medical University, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiyan Chen, MD</last_name>
    <phone>86-20-83827812-10528</phone>
    <email>chenjiyandr@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yingling Zhou, MD</last_name>
    <phone>86-20-83827812-10520</phone>
    <email>gdhzyl@yahoo.com.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiyan Chen, MD</last_name>
      <phone>8620-83827812</phone>
      <phone_ext>10528</phone_ext>
      <email>chenjiyandr@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Yong Liu, MD</last_name>
      <phone>8615920172292</phone>
      <email>liuyongyisheng@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yingling Zhou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ning Tan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2011</study_first_submitted>
  <study_first_submitted_qc>July 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2011</study_first_posted>
  <last_update_submitted>August 20, 2015</last_update_submitted>
  <last_update_submitted_qc>August 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangdong General Hospital</investigator_affiliation>
    <investigator_full_name>Jiyan Chen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>contrast-induced nephropathy</keyword>
  <keyword>contrast medium</keyword>
  <keyword>creatinine clearance</keyword>
  <keyword>coronary angiography</keyword>
  <keyword>diabetes</keyword>
  <keyword>chronic kidney disease</keyword>
  <keyword>predictive model</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

